James Noble
Net worth: 218 278 $ as of 2026-01-30
Net worth: 218 278 $ as of 2026-01-30
James Julian Noble founded Adaptimmune Ltd. in 2008, where he worked as Chief Executive Officer from 2008 to 2014, Adaptimmune Therapeutics Plc in 2008, where he worked as Non-Executive Director from 2019 to 2023, and Immunocore Holdings Plc in 2008, where he worked as Non-Executive Director from 2014 to 2015.
Mr. Noble also currently works at Celleron Therapeutics Ltd., as Chairman, Pneumagen Ltd., as Non-Executive Chairman from 2023, Sutura Therapeutics Ltd., as Chairman, and various other companies.
Mr. Noble also formerly worked at Avidex Ltd., as Chairman & Chief Executive Officer from 2000 to 2014, AfriAg Global Plc, as Non-Executive Chairman from 2010 to 2012, GW Pharmaceuticals Ltd., as Deputy Chairman from 2007 to 2021, and various other companies.
Mr. Noble received his graduate degree in 1980 from the University of Oxford.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OREXO AB 0.19% | 2024-06-04 | 64,516 ( 0.19% ) | 218 278 $ | 2026-01-30 |
| Companies | Position | Start |
|---|---|---|
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Operates as a biopharmaceutical company developing peptide bio molecular medicinal products | Chairman | - |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Chairman | - |
Pneumagen Ltd.
Pneumagen Ltd. Develops glycan targeted carbohydrate binding modules | Chairman | 2023-01-05 |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. Provides cancer treatment services | Chairman | - |
Pneumagen (Holdings) Ltd.
Pneumagen (Holdings) Ltd. Develops broad-spectrum antiviral therapeutics for respiratory infections | Director/Board Member | 2022-12-31 |
| Companies | Position | End |
|---|---|---|
| LAVA THERAPEUTICS N.V. | Director/Board Member | 2025-11-06 |
| OREXO AB | Chairman | 2025-05-07 |
| ADAPTIMMUNE THERAPEUTICS PLC | Founder | 2023-05-31 |
| GW PHARMACEUTICALS PLC | Director/Board Member | 2021-05-04 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 39 |
|---|---|
Ligand UK Ltd.
Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Anthra Pharmaceuticals, Inc.
Anthra Pharmaceuticals, Inc. Medical DistributorsDistribution Services Anthra Pharmaceuticals, Inc. is an American company. | Distribution Services |
Albany Capital Plc
Albany Capital Plc Financial ConglomeratesFinance Invests in pre-IPO companies | Finance |
STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc. Medical SpecialtiesHealth Technology Manufactures dermatology treatment products | Health Technology |
Vestpa Plc
Vestpa Plc Financial ConglomeratesFinance Provides investment services | Finance |
Axellis, Inc.
Axellis, Inc. Medical DistributorsDistribution Services Sells and distributes medical devices | Distribution Services |
Evolve Capital Plc
Evolve Capital Plc Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
AfriAg Global Plc
AfriAg Global Plc Provides investment services | |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Develops pharmaceutical products | Health Technology |
Finsbury Worldwide Pharmaceutical Trust Plc
Finsbury Worldwide Pharmaceutical Trust Plc Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
MediGene AG
MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Advanced Medical Solutions Group Plc
Advanced Medical Solutions Group Plc Medical SpecialtiesHealth Technology Develops and manufactures surgical devices | Health Technology |
Astaire Group Ltd.
Astaire Group Ltd. Investment Banks/BrokersFinance Provides investment banking services | Finance |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astaire Securities Plc
Astaire Securities Plc Investment Banks/BrokersFinance Provides financial services | Finance |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
Commerzbank Finance Ltd.
Commerzbank Finance Ltd. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Prolifix Ltd.
Prolifix Ltd. Miscellaneous Commercial ServicesCommercial Services Operates in the pharmaceutical research and development sector | Commercial Services |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Health Technology |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Commercial Services |
Oxfordshire Biotechnet Ltd.
Oxfordshire Biotechnet Ltd. Investment ManagersFinance Venture Capital Fund | Finance |
China Food Co. Plc
China Food Co. Plc Food: Specialty/CandyConsumer Non-Durables Manufactures sauces, seasonings and condiments | Consumer Non-Durables |
Adprotech Pharmaceuticals, Inc. | |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Northland Capital Partners Ltd.
Northland Capital Partners Ltd. Provides investment banking services | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc Manufactures vaccines and cancer immunotherapy products | |
Pneumagen Ltd.
Pneumagen Ltd. Develops glycan targeted carbohydrate binding modules | |
LAVA Therapeutics NV
LAVA Therapeutics NV Operates as biotechnology company that engages in transforming cancer treatment by developing a platform of novel bispecific antibodies engineered | |
Kleinwort Benson Ltd. (New York) | |
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Operates as a biopharmaceutical company developing peptide bio molecular medicinal products | |
Immunocore Holdings Plc
Immunocore Holdings Plc Operates as a biotechnology company which develops immunotherapies | |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. Provides cancer treatment services | |
Pneumagen (Holdings) Ltd.
Pneumagen (Holdings) Ltd. Develops broad-spectrum antiviral therapeutics for respiratory infections |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition